Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells

Analyst Coverage

Analyst Coverage

Firm Analyst
Cowen
    Boris Peaker
    H.C. Wainwright
      Yi Chen
      Jefferies LLC
        Biren Amin
        Ladenburg Thalmann Securities
          Matthew Kaplan
          ROTH Capital Partners LLC
            Joe Pantginis
            Wedbush Securities, Inc.
              David Nierengarten

              Stemline Therapeutics is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Stemline Therapeutics's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Stemline Therapeutics or its management. Stemline Therapeutics does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.



              Copyright 2017 - Stemline Therapeutics, Inc. All rights reserved